# OnCo record tairx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tairx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tairx" ;
  schema:name "TaiRx"@en ;
  schema:alternateName "台睿生物科技"@en ;
  schema:description "TaiRx is a Taiwan-based biotechnology company that leads 3 cancer trials in OnCo, testing the oral anti-cancer agent CVM-1118 (foslinanib) in hepatocellular carcinoma, neuroendocrine tumours, pancreatic ductal adenocarcinoma and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/tairx/>, <https://www.trx.com.tw> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.trx.com.tw>, <https://clinicaltrials.gov/search?lead=TaiRx%2C%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/sintilimab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:trials <https://onco.cc/trials/nct07521852/>, <https://onco.cc/trials/nct05257590/>, <https://onco.cc/trials/nct03600233/> .
